NIH-funded research R21 grant

Investigating why arteriovenous fistulas fail in patients with kidney disease

Official title: Catheter-associated molecular patterns and arteriovenous fistula failure

Funded at University of Miami School of Medicine · NIH-11011503 · Data updated 2026-11-12

This study is looking into why some arteriovenous fistulas (AVFs) don’t work well for people on hemodialysis, especially how central venous catheters (CVCs) might cause problems, and it hopes to find ways to help more AVFs succeed.

More Arteriovenous Fistula research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Miami School of Medicine
NIH-funded
Lab location1 site (Coral Gables, United States)
Project startJanuary 22, 2024
Project endApril 30, 2025
Funding year2025
Award (this year)$172,688
NIH project number5R21DK138390-02
Project IDNIH-11011503 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with end-stage kidney disease who are starting hemodialysis and may require an arteriovenous fistula for vascular access.

Less likely to help

Patients who are not undergoing hemodialysis or those who do not require vascular access for kidney treatment may not benefit from this research.

What this research studies

This research focuses on understanding the reasons behind the failure of arteriovenous fistulas (AVFs), which are crucial for patients undergoing hemodialysis. It examines the role of central venous catheters (CVCs) and how they may contribute to complications in AVF maturation due to immune responses. By analyzing the molecular patterns and immune cell activity in patients, the study aims to identify potential preventive measures to improve AVF success rates. The research employs a combination of biological assays and patient data to explore these mechanisms.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for ensuring the successful maturation of arteriovenous fistulas, enhancing the quality of life for patients requiring hemodialysis.

How similar studies have gone: Previous research has indicated that immune responses play a significant role in vascular access complications, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of Miami School of Medicine
    Coral Gables, United States
    Active

Researchers

  • Principal investigator: Martinez, Laisel — University of Miami School of Medicine
  • Study coordinator: Martinez, Laisel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.